CRSP EBITDA
Crispr Therapeutics Ag · EBITDA
CRSP EBITDA
Latest reported-$454.02Mperiod ending
CRSP EBITDA (-$6.59M → -$454.02M)
Annual EBITDA
High-resolution chart · PNG
CRSP ebitda history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -558,486,000 | |
| -343,406,000 | |
| -130,885,000 | |
| -626,328,000 | |
| 397,484,000 | |
| -345,251,000 | |
| 51,465,000 | |
| -155,424,000 | |
| -61,624,000 | |
| -13,743,000 | |
| -25,586,000 | |
| -6,589,000 |